These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37357180)

  • 41. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.
    Watson N; Brandel JP; Green A; Hermann P; Ladogana A; Lindsay T; Mackenzie J; Pocchiari M; Smith C; Zerr I; Pal S
    Nat Rev Neurol; 2021 Jun; 17(6):362-379. PubMed ID: 33972773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Creutzfeldt-Jakob disease in Australia 1970-1999.
    Collins S; Boyd A; Lee JS; Lewis V; Fletcher A; McLean CA; Law M; Kaldor J; Smith MJ; Masters CL
    Neurology; 2002 Nov; 59(9):1365-71. PubMed ID: 12427885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prion diseases. The association of bovine spongiform encephalopathy with new variant of Creutzfeldt-Jakob disease].
    Calza L; Manfredi R; Marinacci G; Venturi C; Chiodo F
    Ann Ital Med Int; 1998; 13(4):209-16. PubMed ID: 10349202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic Utility of Cerebrospinal Fluid α-Synuclein in Creutzfeldt-Jakob Disease: A Systematic Review and Meta-Analysis.
    Kong Y; Chen Z; Wang X; Wang W; Zhang J
    J Alzheimers Dis; 2022; 89(2):493-503. PubMed ID: 35912746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study protocol for enhanced CJD surveillance in the 65+ years population group in Scotland: an observational neuropathological screening study of banked brain tissue donations for evidence of prion disease.
    Peden AH; Kanguru L; Ritchie DL; Smith C; Molesworth AM
    BMJ Open; 2019 Oct; 9(10):e033744. PubMed ID: 31662408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creutzfeldt-Jakob disease in Slovenia from 1985 to 2003.
    Popović M; Glavac D; Smerkolj S; Svigelj V; Kalan G; Galvani V; Cernilec M; Bresjanac M
    Wien Klin Wochenschr; 2004 Aug; 116(15-16):524-9. PubMed ID: 15471179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comments on present-day spread and epidemiology of BSE and prion diseases].
    Bodemer W; Kaup FJ
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S21-5. PubMed ID: 14770333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the Australian CJD surveillance system.
    Robotin M
    Commun Dis Intell Q Rep; 2002; 26(2):265-72. PubMed ID: 12206381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of the COVID-19 pandemic on Creutzfeldt-Jakob disease surveillance and patient care in the United Kingdom.
    Watson N; Kirby J; Kurudzhu H; Leitch M; MacKenzie J; Smith-Bathgate B; Smith C; Summers D; Green AJE; Pal S
    Eur J Neurol; 2022 Apr; 29(4):1222-1226. PubMed ID: 34941016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Creutzfeldt-Jakob Disease in South West Sydney 2014-2020: An Unusually High Incidence of a Rare Disease.
    Goire N; Edwards L; Thomas P; Bhaskar SMM; Cordato D; Buckland ME; Beran RG
    Neuroepidemiology; 2022; 56(1):59-65. PubMed ID: 34763340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Human prion diseases: the Hungarian experience].
    Kovács GG; Bakos A; Mitrova E; Minárovits J; László L; Majtényi K
    Ideggyogy Sz; 2007 Nov; 60(11-12):447-52. PubMed ID: 18200749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.
    Chitravas N; Jung RS; Kofskey DM; Blevins JE; Gambetti P; Leigh RJ; Cohen ML
    Ann Neurol; 2011 Sep; 70(3):437-44. PubMed ID: 21674591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002.
    de Pedro-Cuesta J; Glatzel M; Almazán J; Stoeck K; Mellina V; Puopolo M; Pocchiari M; Zerr I; Kretszchmar HA; Brandel JP; Delasnerie-Lauprêtre N; Alpérovitch A; Van Duijn C; Sanchez-Juan P; Collins S; Lewis V; Jansen GH; Coulthart MB; Gelpi E; Budka H; Mitrova E
    BMC Public Health; 2006 Nov; 6():278. PubMed ID: 17096829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically).
    Ryan R; Hill S; Lowe D; Allen K; Taylor M; Mead C
    Cochrane Database Syst Rev; 2011 Mar; (3):CD007578. PubMed ID: 21412905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved Real-Time Quaking Induced Conversion for Early Diagnostics of Creutzfeldt-Jakob Disease in Denmark.
    Bsoul R; Lund EL; Burns K; Andrews M; McKenzie N; Green A; Areškevičiūtė A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The many faces of human prion diseases in Belgium and the world.
    Van Everbroeck B; Pals P; Quoilin S; Martin JJ; Cras P
    Acta Neurol Belg; 2001 Jun; 101(2):81-7. PubMed ID: 11486562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The advances in the early and accurate diagnosis of Creutzfeldt-Jakob disease and other prion diseases: where are we today?
    Kishida H; Ueda N; Tanaka F
    Expert Rev Neurother; 2023; 23(9):803-817. PubMed ID: 37581576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3.
    Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Goebel S; Waniek K; Lachmann I; Zerr I
    J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prion diseases in The Netherlands: twenty-nine years of surveillance].
    Karamujić-Čomić H; Rozemuller AJM; Verbeek MM; Lemstra AW; Ikram MA; van Duijn CM
    Ned Tijdschr Geneeskd; 2022 Sep; 166():. PubMed ID: 36300478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme.
    Mead S; Khalili-Shirazi A; Potter C; Mok T; Nihat A; Hyare H; Canning S; Schmidt C; Campbell T; Darwent L; Muirhead N; Ebsworth N; Hextall P; Wakeling M; Linehan J; Libri V; Williams B; Jaunmuktane Z; Brandner S; Rudge P; Collinge J
    Lancet Neurol; 2022 Apr; 21(4):342-354. PubMed ID: 35305340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.